Compare SDHC & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SDHC | SEER |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.3M | 97.3M |
| IPO Year | 2023 | 2020 |
| Metric | SDHC | SEER |
|---|---|---|
| Price | $13.16 | $1.91 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $14.60 | N/A |
| AVG Volume (30 Days) | 77.6K | ★ 500.7K |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.40 |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $971,116,000.00 | $16,578,000.00 |
| Revenue This Year | $4.21 | $2.14 |
| Revenue Next Year | $11.07 | $25.90 |
| P/E Ratio | $216.67 | ★ N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $11.13 | $1.65 |
| 52 Week High | $23.50 | $2.41 |
| Indicator | SDHC | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 43.71 | 51.55 |
| Support Level | $11.18 | $1.87 |
| Resistance Level | $15.45 | $1.97 |
| Average True Range (ATR) | 0.89 | 0.09 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 18.66 | 35.19 |
Smith Douglas Homes Corpis a builder of single-family homes in communities in certain markets in the southeastern and southern United States. The Company's homes and communities are targeted to first-time and empty-nest homebuyers. The Company currently operates in metropolitan Atlanta, Birmingham, Chattanooga, Central Georgia, Charlotte, Dallas-Fort Worth, Greenville, Alabama Gulf Coast, Huntsville, Nashville, Raleigh and Houston. Its operations are currently organized into ten geographical divisions which comprise two reportable segments. Its Southeast segment consists of its Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of its Alabama, Dallas-Fort Worth, Houston, Nashville, and Alabama Gulf Coast divisions.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.